CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 769674-769817 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/867ebb2be2d466bcb35e5a7319708eaff39c4799","sourcedb":"CORD-19","sourceid":"867ebb2be2d466bcb35e5a7319708eaff39c4799","text":"Due to negative of antigenemia and negative of stool CMV-PCR, oral form ganciclovir was discontinued (12/2-12/23) after discussing with ID man.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T357","span":{"begin":0,"end":143},"obj":"Sentence"}],"attributes":[{"subj":"T357","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T47613","span":{"begin":0,"end":143},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T47613","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1267","span":{"begin":47,"end":52},"obj":"Body_part"}],"attributes":[{"id":"A1267","pred":"uberon_id","subj":"T1267","obj":"http://purl.obolibrary.org/obo/UBERON_0001988"},{"subj":"T1267","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#a5ec93","default":true},{"id":"CORD-19-Sentences","color":"#ec93bf"},{"id":"CORD-19-PD-UBERON","color":"#93d9ec"}]}]}}